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A B S T R A C T
The aqueous extract of Avicenna marina (AM) has been suggested to be useful in the treat-
ment of various diseases. In this study, the protective effect of oral administration ofAvicenna
marina extract against oxidative gastric mucosal injury induced by nonsteroidal anti-
inflammatory drugs (NSAIDs), indomethacin in rats was investigated.The aqueous extract of
Avicenna marina was given by oral gavages (125 mg /kg) three times at 12 h intervals before
administering indomethacin (20 mg/kg).The level of prostaglandin (PGE2) and pHgradientwere
markedly decreased following indomethacin treatment, with increase in acid volume. In ad-
dition, tumor necrosis factor (TNFα), transforming growth factor-β1 (TGF-β1) and the lipid
peroxidation products malondialdehyde (MDA) were significantly increased 6 h after oral ad-
ministration of indomethacin in rats gastric mucosa indicating acute inflammatory injury.
Pretreatment with AM abolished indomethacin induced elevation ofTNF-α,TGF-β1 and MAD
levels. In indomethacin-treated rats, the superoxide dismutase (SOD) and catalase (CAT) ac-
tivities as well as reduced glutathione (GSH) content were significantly diminished in gastric
mucosa. However, pre-administration with AM maintains the level of these parameters near
to the control value. Thus, these results indicate the effective anti-peroxidative and preven-
tive actions of AM against indomethacin-induced gastric mucosal damage.
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Harmful effects of toxic factors such as alcohol, bile salts, and
hydrochloric acids are prevented by biological structures within
the stomach.This high resistance to injuries relies on a number
of physiological responses evoked by the mucosal lining against
potentially harmful luminal agents, as well as the ability of
rapidly repairing the mucosal damage after it occurs [1]. On
the other hand, these protective mechanisms might be
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overcome by injurious factors and a gastric mucosal lesion may
develop. Most of the deleterious effects on gastric mucosa are
caused by nonsteroidal anti- inflammatory drugs (NSAIDs),
which are considered one of the largely used pharmaceutical
agents worldwide [2]. NSAIDs produce both helpful and an-
tagonistic impacts fundamentally by hindering cyclooxygenase
(COX) and subsequently diminishing the production of throm-
boxanes and prostaglandins,which are themediators that signal
inflammation and pain as well as mediating the physiologi-
cal functions [3].
Indomethacin, which is a part of the NSAIDs family, acti-
vates polymorphonuclear granules and induce gastrointestinal
damage in both animals and humans [4,5]. These kinds of pa-
thologies are usually primarily due to damage of the mucosal
cell membranes. Previously, reports have shown that the in-
hibition of prostaglandin synthesis is not the only mechanism
responsible for gastric damage induced by indomethacin [6].
Also, indomethacin might act like a pro-oxidant catalytic and
also initiate LPO by producing ROS, thereby interfering with
the endogenous antioxidant systems of any mucosal cells [7].
Avicenna marina is a mangrove plant known as gray man-
grove tree belonging to the family of Avicenniaceae [8,9].
Phytochemical screening of Avicenna marina aqueous leaf extract
revealed the presence of alkaloids, flavonoids, carbohydrates,
glycosides, tannins, triterpenoids, and steroids [10,11]. It has
been found to possess major therapeutic activity such as an-
tibacterial, anti-helminthic [12], antimicrobial [13], antiviral [14],
antihuman immunodeficiency virus, anti-inflammatory, and
antitumor activity [15]. Mangrove extracts can be a possible
source of mosquito larvicides. Mangrove plants are also re-
ported for their antioxidant, anti-dyslipidemia, antidiarrheal,
anti-filarial, anti-ulcer effect, cardiotonic properties, and an-
tidiabetic effects [16]. Mangrove leaf extracts are nontoxic to
humans and are environmentally friendly as they are less pol-
lutant [17]. This study focused on the antiulcer activity of
Avicenna marina aqueous leaf extract against indomethacin
induced gastric ulceration. To the best of our knowledge, this
is one of the first studies that reported the antiulcer effect of
AM leaves extract.
2. Materials and methods
2.1. Experimental animals
Healthy male Albino Wister rats of about 175 ± 5 g were used
throughout the study. The animals were acclimated to labo-
ratory conditions of 20–22 °C with a 12-h light/dark cycle for
two weeks before experimentation.All rats were fed with a stan-
dard pellet diet and water ad libitum. Care and use of animals
were conducted under supervision of the animal Care Com-
mittee of Mansoura University, Egypt.
2.2. Cold percolation extraction method
Avicenna marina leaves were collected from (Makadi village,
Hurghada region, Egypt) in August 2014.After drying the leaves,
they were pulverized into fine powder using sterilized mortar
and pestle. 200 g of crushed material was taken into 500 ml
of ethanol, kept on a rotary shaker at 120 rpm for 24 h. After
shaking, it was filtered through layers of muslin cloth, centri-
fuged at 1500 rpm for 20 min (Sigma, Laborzentifugen 2K15).
Resultant extracts were evaporated and concentrated to dryness
using the rotary evaporator at 45 °C. The powder was dis-
solved in sterilized water and stored at 4 °C [18].
2.3. Experimental design
The animals were deprived of food for 36 hours before the ex-
periment but had free access to water. Then NSAIDs,
indomethacin was used as the ulcerogenic agent by a single
dose of 20 mg/kg of body weight [19]. Rats were divided into
4 groups, each of 8 animals.The first group did not receive any
treatment and served as a control. The second group, animals
were orally administered with aqueous extract of Avicenna
marinawith a dose of 125 mg/kg body weight thrice in 12 hours
interval [20].The third group, animals received a single dose
of indomethacin orally as 20 mg/kg of body weight.The fourth
group, animals were orally administered with aqueous extract
of Avicenna marina with a dose 125 mg/kg body weight thrice
in 12 hours intervals; after one hour of last administration of
AM, animals received a single dose of indomethacin orally as
20 mg/kg of body weight. After 6 hours of NSAID administra-
tion, the animals were sacrificed by cervical dislocation. The
animals were dissected and the stomach was taken out, the
stomach was opened along the greater curvature and washed
by saline solution.Then, the stomachs were photographed and
the mucosa was exposed for evaluation.
2.4. Biochemical analysis
Biochemical parameters, including malondialdehyde (MDA),
reduced glutathione (GSH), superoxide dismutase (SOD) and
catalase (CAT), were assayed using biodiagnostic kits, Dokki,
Giza, Egypt. Tumor necrosis factor (TNF-α) level was esti-
mated using an ELISA Kit (Diagnostic Products Corp., Los
Angeles, CA, USA).Transforming growth factor β1 (TGF-β1) level
was estimated by flow cytometric analysis. The prostaglan-
din E2 (PGE2) level was quantified with an immune-enzymatic
dosage kit from R&D Systems (USA).
2.5. Animal handling
The stomachs were removed and the gastric contents were col-
lected and drained into a graduated centrifuge tube and
centrifuged at 2000 x g for 15 min using Centurion Scientific
Ltd centrifuge. The supernatant volume and pH were re-
corded with digital pH meter (intelligent meter YK-2001 pH).
2.6. Histopathological study
For histopathological examination, part of the gastric tissue
was removed and was fixed in 10% formalin. After complete
fixation, thin sections were prepared from tissues. Xylol and
Hematoxylin-Eosin was used for clearing and staining, respec-
tively. The slides were examined by microscope.
2.7. Statistical analysis
All results obtained from the study were evaluated by one-
way ANOVA test, and post-comparison was carried out with
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Tukey-test.The values were expressed asmeans ± SE and values
of P < 0.05 were considered statistically significant [21].
3. Results
3.1. Morphological investigation
Fig. 1(A–D) showed the antiulcer activity of AM. (A) Stomachs
of controlled rats showing normal mucosa. (B) Stomachs of rats
showing mucosa with hemorrhagic erosion when treated with
indomethacin (20 mg/kg). (C) Stomachs of rats that received
AM (125 mg/kg) showing normal mucosa. (D) AM and indo-
methacin treated group showing nearly normal mucosa.
3.2. Biochemical investigation
In this study, the oral administration of AM alone did not induce
any obvious changes in the most biochemical parameters com-
pared with the control group. Conversely, significant increases
were demonstrated in the GSH level and CAT activity in the
gastric mucosa. However, the result showed a significant de-
crease in prostaglandin (PGE2) level and pH gradient
accompanied with increase in acid volume in gastric mucosa
in indomethacin treated rats. Meanwhile, pretreatment with
AM recorded a suppression in these values as shown in Fig. 2
and Table 1.
Administration of indomethacin produced a significant in-
crease in MAD content, an index of lipid peroxidation, in gastric
mucosa. This was accompanied by marked inhibition of SOD
and CAT activities in gastric mucosa in indomethacin treated
rats. Oral administration of indomethacin also led to a sig-
nificant decrease in GSH content (Table 1). The pretreatment
by AM prevented the increase of MDA levels and the de-
crease in cellular antioxidants indicated by the activities of SOD
and CAT and GSH concentration in the gastric tissue (Table 2).
As shown in Figs. 3 and 4, the indomethacin treated rats
had significantly higher levels of TNF-α and TGF-β1 com-
pared to the controlled value.The oral pretreatment with plant
extract of Avicenna marina normalized the increase in the levels
of these markers.
3.3. Histopathological investigation
Fig 5. (A–F) Photomicrograph of stomach of rats H.E. staining.
(A,B) Control group stomach showing normal gastric mucosa
and sub-mucosa. Also normal acid producing cells were seen
(HE, A, 100x and B, 400x).
(C–F) Indomethacin treated stomachs showing necrosis of
superficial layer of gastric mucosa (Star) (HE, C,D 100x).
Stomach showing necrosis and desquamation of superfi-
cial layer of gastric mucosa (HE, E,F, 400x).
M, mucosa; SM, submucosa; MP, Muscularis propria; white
arrow showing base of ulcer, black arrow showing fibrosis, arrow
head showing leukocyte infiltration.
Fig 6. (A–D) Stomach of AM group showing normal gastric
mucosa and submucosa (HE, A, 100x and B, 400x).
(C,D) Stomach of AM and indomethacin group, no ulcers
were seen. Normal lining epithelium of gastric mucosa with
mild congestion (HE, C, 100x and D, 400x).
4. Discussion
NSAIDs are believed to be the most common causative factor
in gastric mucosal injury [22]. On the other hand, the gastric
Fig. 1 – Antiulcer activity of mangrove polyherbal formulation; (A) Stomach of control rat; (B) Stomach of rat showing
mucosa with hemorrhagic erosion when treated with indomethacin (20 mg/kg); (C) Stomach of rat that received mangrove
(125 mg/kg) showing normal mucosa; (D) Mangrove (125 mg/kg b.w.) + indomethacin (20 mg/kg) treated group showing
normal mucosa.
157e g y p t i an j o u rna l o f b a s i c and a p p l i e d s c i e n c e s 3 ( 2 0 1 6 ) 1 5 5 – 1 6 3
mucosal defense mechanisms include several protective factors
which allow the mucosa to resist frequent exposure to dam-
aging factors [1,23]. One of the most important gastric mucosal
defense mechanisms is prostaglandin.The gastric mucosa rep-
resents a source of continuous prostaglandin production, such
as PGE2 and PGI2, which are regarded as crucial factors for the
maintenance of mucosal integrity and protection against in-
jurious factors [24]. Prostaglandins can stimulate almost all of
the mucosal defense mechanisms such as stimulating mucous
and bicarbonate production, increasing mucosal blood flow,
Fig. 2 – Effect of Avicenna marina extract (125 mg/kg) on the levels of prostaglandin (PGE2; μg/g) in the stomach of different
animal groups. The values are expressed as means ± SE (n = 8). Different superscript letters indicate significant difference at
P ≤ 0.05. a: Compared with control group; b: Compared with Indomethacin group. AM, aqueous extract of Avicenna marina.
Indometh, indomethacin.
Table 1 – Effect of Avicenna marina extract (125 mg/kg) on the values of PH and acid volume in the stomach in different
animal groups.
Group parameters Control AM Indometh. AM + Indometh
pH
(value)
6.49 ± 0.13 6.64 ± 0.09 3.03a ± 0.22 5.92a,b ± 0.07
Acid volume
(ml)
2.56 ± 0.09 2.44 ± 0.13 6.32a ± 0.17 2.94b ± 0.08
The values are expressed as the means ± SE (n = 8). Different superscript letters indicate a significant difference at P ≤ 0.05.
a Compared with control group.
b Compared with Indomethacin group.
AM ,aqueous extract of Avicenna marina; Indometh, indomethacin.
Table 2 – Effect of Avicenna marina extract (125 mg/kg) on the levels of lipid peroxidation product MDA (nmol/mg wet
tissue), superoxide dismutase (SOD, u/g wet tissue), catalase (CAT, u/g wet tissue), and glutathione (GSH, mg/g wet
tissue) in the stomach of different animal groups.
Group parameters Control AM Indometh. AM + Indometh.
MDA
(nmol/g)
9 33.97 ± 1.32 58.56a ± 1.13 32.54b ± 1.01
SOD
(U/g)
1179.16 ± 14.89 1207 ± 24.85 695.33a ± 22.93 1135.31b ± 37.66
CAT
(U/g)
0.025 ± 0.0013 0.030a ± 0.0009 0.019a ± 0.0011 0.026b ± 0.0007
GSH
(mg/-g)
0.30 ± 0.01 0.35a ± 0.01 0.25a ± 0.013 0.29 ± 0.009
The values are expressed as the means ± SE (n = 8). Different superscript letters indicate a significant difference at P ≤ 0.05.
a Compared with control group.
b Compared with indomethacin group.
AM, aqueous extract of Avicenna marina; Indometh, indomethacin.
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accelerating epithelial restitution and also mucosal healing in
addition to reducing acid output [25]. Also, prostaglandins are
known to inhibit mast cells activation as well as leukocytes
and platelets adhesion to the vascular endothelium [26].
In the present study, the results recorded a significant de-
crease in the level of PGE2 [Fig. 2] and pH gradient with
increment in acid volume in indomethacin treated rats com-
pared to the corresponding controls [Table 1]. These findings
may be due to indomethacin which produces anti-inflammatory
effects by inhibiting cyclooxygenase enzymes which by turn
suppresses the formation of prostaglandins and throm-
boxane from arachidonic acid [27,28]. Moreover, prostaglandins
reduce the activation of neutrophils and the local release of
reactive oxygen species (ROS). In addition, the endothelium of
mucosal microcirculation produces prostacyclin which will be
highly relevant in ensuring the tonic inhibition of neutrophil
adhesion [29,30].Therefore, indomethacin can shift the mucosal
balance toward the recruitment and endothelial adhesion of
circulating neutrophils by the inhibition of prostaglandin bio-
synthesis [28,31]. Neutrophils also clog the microvasculature
causing a local drop inmucosal blood flow and amarked release
of tissue damaging factors, like proteolytic enzymes and
Fig. 3 – Effect of Avicenna marina extract (125 mg/kg) on the levels of tumor necrosis factor (TNF-α μg/g) in the stomach of
different animal groups. The values are expressed as means ± SE (n = 8). Different superscript letters indicate significant
difference at P ≤ 0.05. a: Compared with control group; b: Compared with indomethacin group. AM, aqueous extract of
Avicenna marina. Indometh, indomethacin.
Fig. 4 – Effect of Avicenna marina extract (125 mg/kg) on the percentage of transforming growth factor (TGF-β 1%) in the
stomach of different animal groups. The values are expressed as means ± SE (n = 8). Different superscript letters indicate a
significant difference at P ≤ 0.05. a: Compared with control group; b: Compared with indomethacin group. AM, aqueous
extract of Avicenna marina. Indometh, indomethacin.
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leukotrienes,which increase the vascular tone, exacerbate tissue
ischemia, stimulate ROS production, and eventually promote
the destruction of the intestinal matrix, leading to a severe
degree of tissue necrosis, particularly in the presence of a low
luminal pH [32,33]. Just as anticipated above, cyclooxygenase-
dependent inhibition connected with bicarbonate secretion
contributes also to the gastric mucosal injury elicited from
NSAIDs [34].
The obtained gastric mucosal injury in indomethacin treated
rats as shown in Fig. 1, may be due to the role of oxygen radi-
cals, LPO and lowered antioxidants levels, this goes in
accordance with Naito et al. [35], who suggested that LPO me-
diated by oxygen radicals plays an important role in the
mechanism of ulcer aggravation induced by indomethacin.The
lipid peroxidation product, MDA, is more cytotoxic to cells and
affects themembrane structure and function [36]. In the present
study, indomethacin produced a significant rise in MDA con-
centration, accompanied by severe ulceration. In concomitant
with increased LPO products, there was an inhibition in SOD
and CAT activities as well as GSH content in indomethacin
treated rats compared to the corresponding controls (Table 2).
The decline in SOD, CAT activities and GSH level in the gastric
mucosa of rats treated with indomethacin may lead to an in-
crease in LPO and hence may render the gastric mucosa more
susceptible to injury by indomethacin. Thus, the inhibition of
antioxidants leads to the accumulation of ROS [19,37].This study
Fig. 5 – (A–F) Photomicrograph of stomach of rats HE staining. (A,B) Control stomach showing normal gastric mucosa and
submucosa. Also normal acid producing cells were seen (HE, A, 100x and B, 400x). (C–F) Treated stomach showing necrosis
of superficial layer of gastric mucosa (Star). (HE, C,D, 100x) Stomach showing necrosis and desquamation of superficial layer
of gastric mucosa (HE, E,F, 400x). M, mucosa; SM, submucosa; MP, Muscularis properia; white arrow showing base of ulcer,
black arrow showing fibrosis, arrow head showing leukocyte infiltration.
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proved that the level of GSH and CAT activity significantly in-
creased in the AM treated group, and this may be due to its
initiating effect on GSH and CAT synthesis.
Moreover, our results recorded a significant increase in tumor
necrosis factor, alpha (TNF-α) in indomethacin treated rats as
shown in Fig. 3.This result is in agreement withWhittle (2002)
[28], who recorded that, oxidative damage associated with in-
domethacin treatment caused dramatic enhancement in gastric
epithelial cell apoptosis triggered by increased expression of
TNF-α. Also, the increase in mucosal blood flow is mediated
by NO release, and there is experimental evidence demon-
strating that NO protects the gastric mucosa against injury
induced by indomethacin [38].
Transforming growth factor-β1 (TGF-β1) is usually a mul-
tifunctional cytokine. It regulates cell growth, differentiation,
and extracellular matrix production [39]. Also, TGF-β1 is con-
sidered as a good inflammatory marker of the cells [40]. In the
present study,TGF-β1 was significantly elevated in indometha-
cin treated rats when compared with the corresponding controls
(Fig. 4).These results are usually attributed to the gastric injury
relevant to indomethacin administration. Moreover, the integ-
rity of gastric epithelium is actually maintained via a continuous
process of cell renewal ensured bymucosal progenitor cells [41].
These cells are submitted to a continuous, well harmonized,
and controlled growth, which ensures the replacement of
damaged or aged cells on the epithelial surface. The cell turn-
over process is controlled by growth factors [42]. In particular,
a marked expression of epidermal growth factor receptor (EGF-R)
has been detected in gastric progenitor cells. This receptor is
activated via mitogenic growth factors, such as transforming
growth factor-β (TGF-β1) and insulin-like growth factor-1 (IGF-
1) [43].Also, PGE2 and gastrin are able to transactivate the EGF-R
as well as promote the activation connected with mitogen-
activated protein kinase pathway, with consistent stimulation
associated with cell proliferation [44].
Unrefined extracts from some therapeutic tannin-rich plants
are generally utilized worldwide to treat gastric ulcer [45].
Tannins are known to exist in mangrove species, which com-
prises fundamentally of dense tannins or proanthocyanidins
[46].
Pretreatment with the AM reflected a tendency to in-
crease PGE2 production in spite of indomethacin-induced
depletion. These results may be attributed to the polypheno-
lic compounds found in AM [47]. Phenols stimulate PGE
formation based on their action as co-substrates for the per-
oxidase reaction [48]. Hence, the leaf extract of AM has the
protective effect on the stomach against NSAIDs induced gastric
ulcer, and this may be attributed to polyphenolic compounds
[49].
In the present study, the gastroprotective properties of AM
leaf extract may be attributed to the presence of several com-
pounds. As, in a previous study of the author [10], the
phytochemical screening ofAM leaves extract revealed that the
presenceofphenolic-flavonoids; alkaloids; terpenoides; steroides;
cardiac glycosides; tannins; flavonoids and saponines.Themajor
active components of the AM are polyphenols, represented
majorly by polymeric tannins (80%), hydrolysable tannins (20%)
and catechin, chlorogenic, gallic and elagic acids as well as
gallotannins, elagitannins, and condensed tannins.These sub-
stances which are portrayed by their polyphenolic nature have
indicated cytoprotective properties [48] and have been related
to antiulcerogenic action in different plants [49,50].On the other
hand, tannins may counteract ulcer advancement because of
their protein precipitating andvasoconstricting effects [49].Their
astringent action can help precipitating microproteins on the
ulcer site, thereby forming an impervious layer over the lining,
whichhinders gut secretionsandprotects theunderlyingmucosa
from toxins and other irritants [51,52].
The results on histopathological investigation of the gastric
mucosa of rats indicated that the pretreatment with AM
Fig. 6 – (A–D) Stomach of mangrove group showing normal gastric mucosa and submucosa. (HE, A, 100x and B, 400x). (C,D)
Stomach of AM and indomethacin group showing no ulcer were seen. Normal lining epithelium of gastric mucosa with
mild congestion (HE, C, 100x and D, 400x).
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absolutely inhibited the indomethacin-induced congestion,
hemorrhage, inflammations, erosions, and ulceration.
In conclusion, it appears that AM has an antiulcerogenic
effect that will protect the gastric mucosa from damage induced
by indomethacin.This protective action may be due to the in-
hibition of basal gastric acid secretion and stimulation of mucus
secretion. Also, the antiulcer effect of AM may be attributed
to the presence of flavonoids in the aqueous extract, al-
though the involvement of other chemical compounds in the
plant cannot be ruled out. The data obtained so far do not in-
dicate, however,which specificmechanism(s) is (are) responsible
for the anti-secretory, antiulcer, and cytoprotective activities.
Further studies are required to isolate the antiulcer com-
pounds and to elucidate their mechanism of action.
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